Nuclear Street.

← News archive

Mirion Technologies to Provide Radiation Monitoring Systems for the Slovakian Mochovce Nuclear Power Plants

Source:

Archived news summary. This item reflects its original publication date. Follow the source link below for the publisher’s full article.

The Mirion equipment includes over 350 radiation monitors and supporting processing electronics from the MGP Instruments RAMSYSTM product line, covering all aspects of radiation monitoring including several types of monitors that conform to the U.S. Nuclear Regulatory Commission (NRC) 10 CFR 50 Appendix B Quality Assurance Program

 – By April Murelio –

The Mirion Technologies Radiation Monitoring Systems (RMS) Division announced that it has received an order to supply a full suite of monitors for the Mochovce 3 & 4 radiation monitoring systems. Both nuclear power plants are VVER 440 reactors and owned by the Slovakian energy company Slovenské Elektrárne a.s.

The Mirion equipment includes over 350 radiation monitors and supporting processing electronics from the MGP Instruments RAMSYSTM product line, covering all aspects of radiation monitoring including several types of monitors that conform to the U.S. Nuclear Regulatory Commission (NRC) 10 CFR 50 Appendix B Quality Assurance Program.

These systems will be installed over the next two years by VUJE a.s., Mirion’s local design and engineering partner on this project.

“We are honored to assist Slovenské Elektrárne a.s. with their instrumentation needs,” stated Jean-Louis Gouronc, President of Mirion’s RMS Division. “Our standard monitoring systems are designed to meet rigorous technical, quality and commercial requirements.”

Mirion Technologies is a global provider of radiation detection, measurement, analysis and monitoring products and services to the nuclear, defense and medical end markets. Mirion has facilities in Europe, Asia, and North America. Mirion Technologies is headquartered in the San Francisco Bay area and is a portfolio company of American Capital (NASDAQ:ACAS).


Questions about this archived item? Contact Nuclear Street.